Grebely, Jason

Publishing since 2005 (Junior)

Has published 19 publications in 6 years

Number of publications published per year by Grebely, Jason. (Source : PubMed)

Distribution of publications types for Grebely, Jason. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.  Drug Alcohol Depend  2010;107;2-3  
•  Grebely J, Raffa JD, Lai C, Kerr T, Fischer B, Krajden M, Dore GJ, Tyndall MW. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.  J. Viral Hepat.  2010  
•  Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.  Gastroenterology  2010;138;1  
•  Grebely J, Matthews GV, Petoumenos K, Dore GJ. Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.  J. Viral Hepat.  2009  
•  Grebely J, Thomas DL, Dore GJ. HCV reinfection studies and the door to vaccine development.  J. Hepatol.  2009;51;4  
•  Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B. Primary drug resistance in antiretroviral-naïve injection drug users.  Int. J. Infect. Dis.  2009;13;5  
•  Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, Tyndall MW. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.  J. Viral Hepat.  2009;16;5  
•  Matthews GV, Grebely J, Dore GJ. The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.  J. Hepatol.  2008;49;3  
•  Raffa JD, Tossonian HK, Grebely J, Petkau AJ, DeVlaming S, Conway B. Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations.  J. Acquir. Immune Defic. Syndr.  2008;47;3  
•  Grebely J, Genoway KA, Raffa JD, Dhadwal G, Rajan T, Showler G, Kalousek K, Duncan F, Tyndall MW, Fraser C, Conway B, Fischer B. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.  Drug Alcohol Depend  2008;93;1-2  

[ See timeline ] [ See all publications ]